Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The transcription factor Zfp281 sustains CD4+ T lymphocyte activation through directly repressing Ctla-4 transcription.

Guo J, Xue Z, Ma R, Yi W, Hui Z, Guo Y, Yao Y, Cao W, Wang J, Ju Z, Lu L, Wang L.

Cell Mol Immunol. 2019 Sep 11. doi: 10.1038/s41423-019-0289-y. [Epub ahead of print]

PMID:
31511645
2.

The transcription factor Zfp281 controls embryonic stem cell pluripotency by direct activation and repression of target genes.

Wang ZX, Teh CH, Chan CM, Chu C, Rossbach M, Kunarso G, Allapitchay TB, Wong KY, Stanton LW.

Stem Cells. 2008 Nov;26(11):2791-9. doi: 10.1634/stemcells.2008-0443. Epub 2008 Aug 28.

3.

Zfp281 functions as a transcriptional repressor for pluripotency of mouse embryonic stem cells.

Fidalgo M, Shekar PC, Ang YS, Fujiwara Y, Orkin SH, Wang J.

Stem Cells. 2011 Nov;29(11):1705-16. doi: 10.1002/stem.736.

4.

Expression and functional significance of CTLA-4, a negative regulator of T cell activation.

Kosmaczewska A, Ciszak L, Boćko D, Frydecka I.

Arch Immunol Ther Exp (Warsz). 2001;49(1):39-46. Review.

PMID:
11266089
5.

Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses.

Chambers CA, Kuhns MS, Allison JP.

Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8603-8.

6.

CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.

Zhou J, Bashey A, Zhong R, Corringham S, Messer K, Pu M, Ma W, Chut T, Soiffer R, Mitrovich RC, Lowy I, Ball ED.

Biol Blood Marrow Transplant. 2011 May;17(5):682-92. doi: 10.1016/j.bbmt.2010.08.005. Epub 2010 Aug 14.

7.

Zfp281 (ZBP-99) plays a functionally redundant role with Zfp148 (ZBP-89) during erythroid development.

Woo AJ, Patry CA, Ghamari A, Pregernig G, Yuan D, Zheng K, Piers T, Hibbs M, Li J, Fidalgo M, Wang JY, Lee JH, Leedman PJ, Wang J, Fraenkel E, Cantor AB.

Blood Adv. 2019 Aug 27;3(16):2499-2511. doi: 10.1182/bloodadvances.2018030551.

8.

Zfp281 is essential for mouse epiblast maturation through transcriptional and epigenetic control of Nodal signaling.

Huang X, Balmer S, Yang F, Fidalgo M, Li D, Guallar D, Hadjantonakis AK, Wang J.

Elife. 2017 Nov 23;6. pii: e33333. doi: 10.7554/eLife.33333.

9.

Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation.

Chain JL, Martin AK, Mack DG, Maier LA, Palmer BE, Fontenot AP.

J Immunol. 2013 Aug 15;191(4):1648-56. doi: 10.4049/jimmunol.1300282. Epub 2013 Jul 12.

10.

Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sézary syndrome.

Gibson HM, Mishra A, Chan DV, Hake TS, Porcu P, Wong HK.

J Invest Dermatol. 2013 Jan;133(1):249-57. doi: 10.1038/jid.2012.265. Epub 2012 Sep 6.

12.

ZFP281 Recruits MYC to Active Promoters in Regulating Transcriptional Initiation and Elongation.

Luo Z, Liu X, Xie H, Wang Y, Lin C.

Mol Cell Biol. 2019 Nov 25;39(24). pii: e00329-19. doi: 10.1128/MCB.00329-19. Print 2019 Dec 15.

PMID:
31570506
13.

Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge.

Rowe JH, Johanns TM, Ertelt JM, Lai JC, Way SS.

Immunology. 2009 Sep;128(1 Suppl):e471-8. doi: 10.1111/j.1365-2567.2008.03001.x. Epub 2008 Dec 17.

14.

Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).

Griffin MD, Hong DK, Holman PO, Lee KM, Whitters MJ, O'Herrin SM, Fallarino F, Collins M, Segal DM, Gajewski TF, Kranz DM, Bluestone JA.

J Immunol. 2000 May 1;164(9):4433-42.

15.

Striking a balance: regulation of transposable elements by Zfp281 and Mll2 in mouse embryonic stem cells.

Dai Q, Shen Y, Wang Y, Wang X, Francisco JC, Luo Z, Lin C.

Nucleic Acids Res. 2017 Dec 1;45(21):12301-12310. doi: 10.1093/nar/gkx841.

16.

ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation.

Nicolai S, Pieraccioli M, Smirnov A, Pitolli C, Anemona L, Mauriello A, Candi E, Annicchiarico-Petruzzelli M, Shi Y, Wang Y, Melino G, Raschellà G.

Mol Oncol. 2019 Nov 29. doi: 10.1002/1878-0261.12605. [Epub ahead of print]

17.

CTLA-4 and CD4+ CD25+ regulatory T cells inhibit protective immunity to filarial parasites in vivo.

Taylor MD, Harris A, Babayan SA, Bain O, Culshaw A, Allen JE, Maizels RM.

J Immunol. 2007 Oct 1;179(7):4626-34.

18.

Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production.

Curran MA, Kim M, Montalvo W, Al-Shamkhani A, Allison JP.

PLoS One. 2011 Apr 29;6(4):e19499. doi: 10.1371/journal.pone.0019499.

19.

Zfp281 Shapes the Transcriptome of Trophoblast Stem Cells and Is Essential for Placental Development.

Ishiuchi T, Ohishi H, Sato T, Kamimura S, Yorino M, Abe S, Suzuki A, Wakayama T, Suyama M, Sasaki H.

Cell Rep. 2019 May 7;27(6):1742-1754.e6. doi: 10.1016/j.celrep.2019.04.028.

20.

Supplemental Content

Support Center